WHAT IS Qualia Senolytic?

Qualia Senolytic contains a combination of nine vegan ingredients. It was formulated to be a two-day rejuvenation regimen to support healthy aging in an area called “cellular senescence.”*

WHAT IS THE RAND SF-36?

The 36-Item Short Form Survey Instrument (SF-36) was developed at RAND as part of the Medical Outcomes Study. It is one of the most widely used tools to assess health status and health-related quality of life. The SF-36 scores eight health concepts: (1) General Health, (2) Vitality (i.e., energy and fatigue levels), (3) Psychological Wellness (4) Emotional Health (i.e., to what degree emotional health influences time spent and ability to accomplish work or daily activities), (5) Physical Health (i.e., to what degree physical health influences time spent and ability to accomplish work or daily activities), (6) Social Functioning (i.e., ability to engage in normal social activities), (7) Physical Functioning (i.e., ability to perform physical activities), and (8) Bodily Comfort.

HOW THE PILOT STUDY WORKED

Nineteen adults (10 males and 9 females) ranging in age from 29 to 58 years old completed the Qualia Senolytic SF-36 pilot study between late October and early December 2022.

During the study, participants took six capsules of Qualia Senolytic for two consecutive days, followed by twelve days with no supplementation. The two-day regimen was repeated three times. Because of this schedule, participants took Qualia Senolytic for a total of six days over about one month. 

Participants were asked to take the full quantity of Qualia Senolytic (six capsules) anytime in the morning, with or without food, on these days. 

Prior to beginning supplementation and after the third use cycle participants completed the RAND SF-36.

RESULT HIGHLIGHTS

Qualia Senolytic Supports Enhanced Health and Health-Related Quality of Life†*

Seven of the eight health concepts assessed by the RAND SF-36 improved after three use cycles of Qualia Senolytic.†* 

Greatest self-reported improvements from baseline levels for the group of participants occurred with: (1) Emotional Health (78% improvement), (2) Physical Health (42% improvement), (3) and Vitality (38% improvement). There were also perceived improvements in Social Functioning (23%), General Health (21%), Psychological Wellness (17%), and Bodily Comfort (8%).†*

Figure 1. Percentage Improvements from Baseline in the 8 SF-36 Health Concepts After Taking Qualia Senolytic

Seventeen of 19 (89%) participants reported improvements in either General Health, Vitality, or both. Fourteen of 19 (74%) reported improvements in Vitality (i.e., increased energy) and 13 of 19 (68%) reported improved General Health.

*Disclaimer: Several factors should be kept in mind when interpreting the results. The study contained a small number of participants and was not placebo-controlled. While Neurohacker Collective is encouraged by the results of this small preliminary study, further controlled, larger studies will be required to verify the findings.

Qualia Senolytic was Highly Rated and Well-Liked††*

After completing the study, participants were asked to rate their overall experience of taking Qualia Senolytic. Answer choices were Excellent, Good, No Effect, Not Good, and Awful. About 9 out of 10 (89%) of participants rated Qualia Senolytic as Good or Excellent.††*

Participants were also asked about their interest in continuing to take Qualia Senolytic. Ninety-four percent of participants answered they’d want to continue taking it.††*

The Ultimate Recipe For Supporting Healthy Cell Repair and Rejuvenation

Qualia Senolytic represents the culmination of years of research into the biological mechanisms of aging. This two-day rejuvenation regimen may hold the key to enhancing cellular health and supporting tissue revitalization throughout the body as you age revitalizing aging tissues throughout the body.*

†Based on baseline and final RAND SF-36 responses.
††Based on proprietary health survey data.
Disclaimer: Several factors should be kept in mind when interpreting the results. The study contained a small number of participants and was not placebo-controlled. While Neurohacker Collective is encouraged by the results of this small preliminary study, further controlled, larger studies will be required to verify the findings.